At a glance
ClinicalIndex Comparison RecordN/ACompleted· 289 enrolled
Drug / intervention
Uphold Lightweight Vaginal Support System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of Uphold LITE Versus Native Tissue for the Treatment of Women With Anterior/Apical Pelvic Organ Prolapse
In Brief
A clinical study evaluating Uphold Lightweight Vaginal Support System and Traditional native tissue repair for Pelvic Organ Prolapse. Completed, enrolled 289 participants across 28 sites.
Detailed Summary
The purpose of this study is to compare transvaginal mesh repair to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPelvic Organ Prolapse
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 2013
Enrollment StartOct 2013
Primary CompletionFeb 2020
TodayJul 2026
First PostedAug 7, 2013
Enrollment StartOct 10, 2013
Primary CompletionFeb 12, 2020
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 12.9 years ago
Interventions
Uphold Lightweight Vaginal Support Systemdevice
Pelvic organ prolapse repair via transvaginal mesh (Uphold LITE)
Traditional native tissue repairprocedure
Sarcrospinous ligament fixation or uterosacral ligament suspension and/or colporrhaphy